Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 10, 2007, Pages 1877-1885

  Castro Galache, María D ^a   Menéndez Gutiérrez, Maria P ^b   Garcia, Estefania Carrasco ^a   Garcia Morales, Pilar ^a   Martinez Lacaci, Isabel ^a   Saceda, Miguel ^b   Ferragut, Jose A ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Apoptosis; Histone deacetylase inhibitors; Multidrug resistance; Protein kinase C

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; PROTEIN KINASE C ALPHA; TRICHOSTATIN A; VORINOSTAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LEVEL; CELL MUTANT; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA L 1210; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN DEPLETION; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HISTONE DEACETYLASES; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA; MICE; MUTANT PROTEINS; PROTEIN KINASE C-ALPHA; TRANSFECTION; TUMOR CELLS, CULTURED;

MURINAE;

EID: 34548230535     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.05.007     Document Type: Article

References (35)

1. Aleu J., Ivorra I., Lejarreta M., Gonzalez-Ros J.M., Morales A., and Ferragut J.A. Functional incorporation of P-glycoprotein into xenopus oocyte plasma membrane fails to elicit a swelling-evoked conductance. Biochem. Biophys. Res. Commun. 237 (1997) 407-412
2. Alkan S., Huang Q., Ergin M., Denning M.F., Nand S., Maududi T., et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukaemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am. J. Hematol. 79 (2005) 97-106
3. Aquino A., Warren B.S., Omichinski J., Hartman K.D., and Glazer R.I. Protein kinase C-γ is present in adriamycin resistant HL-60 leukemia cells. Biochem. Biophys. Res. Commun. 166 (1990) 723-728
4. Batlle E., Verdu J., Dominguez D., Llosas M.M., Diaz V., Loukili N., et al. Protein kinase C-α activity inversely modulates invasion and growth of intestinal cells. J. Biol. Chem. 273 (1998) 15091-15098
5. Bellamy W.T. P-glycoproteins and multidrug resistance. Ann. Rev. Pharmacol. Toxicol. 36 (1996) 161-183
6. Borst P., and Oude Elferink R. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71 (2002) 537-592
7. Brugger D., Brischwein K., Liu C., Bader P., Niethammer D., Gekeler V., et al. Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. Anticancer Res. 22 (2002) 4229-4232
8. Budworth J., Gant T.W., and Gescher A. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/ADR breast carcinoma cells. Br. J. Cancer 75 (1997) 1330-1335
9. Camarasa M.V., Castro-Galache M.D., Carrasco-Garcia E., Garcia-Morales P., Saceda M., and Ferragut J.A. Differentiation and drug resistance relationships in leucemia cells. J. Cell Biochem. 94 (2005) 98-108
10. Castro-Galache M.D., Ferragut J.A., Barbera V.M., Martin-Orozco E., Gonzalez-Ros J.M., Garcia-Morales P., et al. Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors. Int. J. Cancer 104 (2003) 579-586
11. Del Bufalo D., Biroccio A., Trisciuoglio D., Bruno T., Floridi A., Aquino A., et al. Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used. Eur. J. Cancer 38 (2002) 2455-2462
12. Drummond D.C., Noble C.O., Kirpotin D.B., Guo Z., Scott G.K., and Benz C.C. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 495-528
13. Fine R.L., Chambers T.C., and Sachs C.W. Advances in cancer treatment: The Chabner symposium. The Oncol. 1 (1996) 261-268
14. German U.A., Cambers T., Ambudkar C., Licht S.V., Cardarelli T., Pastan C.O., et al. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J. Biol. Chem. 271 (1996) 1708-1716
15. Gill P.K., Gescher A., and Gant T.W. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and θ. Eur. J. Biochem. 268 (2001) 4151-4157
16. Gonzalez-Guerrico A.M., Meshki J., Xiao L., Benavides F., Conti C.J., and Kazanietz M.G. Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J. Biochem. Mol. Biol. 38 (2005) 639-645
17. Goodfellow H.R., Sardini A., Ruetz S., Callaghan R., Gros P., McNaughton P.A., et al. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J. Biol. Chem. 271 (1996) 13668-13674
18. Gottesman M.M. Mechanisms of drug resistance. Annu. Rev. Med. 53 (2002) 615-627
19. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. 2 (2002) 48-58
20. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-422
21. Hampson P., Chahal H., Khanim F., Hayden R., Mulder A., Assi L.K., et al. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 106 (2005) 1362-1368
22. Hess-Stumpp H. Histone deacetylase inhibitors and cancer: From cell biology to the clinic. Eur. J. Cell Biol. 84 (2005) 109-121
23. Ido M., Sato K., Sakurai M., Inagaki M., Saitoh M., Watanabe M., et al. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide. Cancer Res. 47 (1987) 3460-3463
24. Kazanietz M.G. Targeting protein kinase C and "non-kinase" phorbol ester receptors: Emerging concepts and therapeutic implications. Biochim. Biophys. Acta 1754 (2005) 296-304
25. Ko C.H., Shen S.C., Hsu C.S., and Chen Y.C. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: Roles of protein kinase C, cytochrome c, and caspase cascade. Biochem. Pharmacol. 69 (2005) 913-927
26. Kwon S.H., Ahn S.H., Kim Y.K., Bae G.U., Yoon J.W., Hong S., et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J. Biol. Chem. 277 (2002) 2073-2080
27. Liao Y.F., Hung Y.C., Chang W.H., Tsay G.J., Hour T.C., Hung H.C., et al. The PKC delta inhibitor, rottlerin, induces apoptosis in haematopoietic cell lines through mitochondrial membrane depolarization and caspases's cascade. Life Sci. 77 (2005) 707-719
28. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3003-3007
29. Ruefli A.A., Bernhard D., Tainton K.M., Kofler R., Smyth M.J., and Johnstone R.W. Suberoylanilide hydroxamic acid acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells. Int. J. Cancer 99 (2002) 292-298
30. Sharom F.-J. The P-glycoprotein efflux pump: How does it transport drugs?. J. Membr. Biol. 160 (1997) 161-175
31. Soto F., Canaves J.M., Gonzalez-Ros J.M., and Ferragut J.A. Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells. FEBS Lett. 301 (1992) 119-123
32. Soto F., Planells-Cases R., Canaves J.M., Ferrer-Montiel A.V., Aleu J., Gamarro F., et al. Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells. Eur. J. Cancer 29A (1993) 2144-2150
33. Tan B., Piwnica-Worms D., and Ratner L. Multidrug resistance transporters and modulation. Curr. Opin. Oncol. 12 (2000) 450-458
34. Yeow W.S., Ziauddin M.F., Maxhimer J.B., Shamimi-Noori S., Baras A., Chua A., et al. Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01. Br. J. Cancer 94 (2006) 1436-1445
35. Zhu W.H., and Loh T.T. Differential effects of phorbol ester on apoptosis in HL-60 promyelocitic leukaemia cells. Biochem. Pharmacol. 51 (1996) 1229-1236